Previous Close | 2.7000 |
Open | 2.7000 |
Bid | 2.2000 |
Ask | 2.6500 |
Strike | 130.00 |
Expire Date | 2024-10-18 |
Day's Range | 2.7000 - 2.7000 |
Contract Range | N/A |
Volume | |
Open Interest | 11 |
QIAGEN (QGEN) launches the new QIAseq Multimodal DNA/RNA Lib Kit, facilitating multiomic studies and advancing precision medicine.
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
The commercialization of Teleflex's (TFX) UroLift in Japan has been a significant step toward making this therapy more broadly available to men suffering from BPH.